Comment on “Impact of a Pharmacist Driven Penicillin Allergy De-labeling Protocol on Rates of Reported Allergy in the Intensive Care Unit”

Abstract

Get full access to this article

View all access options for this article.

References

Mahmud

Kokoy

Stollings

, et al. Impact of a pharmacist-driven penicillin allergy de-labeling protocol on rates of reported allergy in the intensive care unit. Hosp Pharm. Published online 2025. doi:10.1177/00185787251337625

Shapiro Ben David

Kantor

Hemo

, et al. Reported penicillin allergy in Israel: clinical outcomes and antibiotic costs in a nationwide population-based cohort study. J Aller Clin Immunol. Published online 2025. doi:10.1016/j.jacig.2025.100565

Göcebe

Kommoss

Hartmann

Enk

Schäkel

Implementing PEN-FAST for penicillin allergy delabeling in a high-prevalence population. J Deutsch Dermatol Gesellsc. Published online 2025. doi:10.1111/ddg.15862

Viju

Souman

Muchukota

Madhuvan

Rani

Clinical pharmacists vs. antimicrobial resistance: evidence-based strategies and stewardship impact in modern healthcare: a review. J Drug Deliv Ther. 2025;15:199-206. doi:10.22270/jddt.v15i8.7286

Lee

Turner

Kenny

Analysis of stepped-wedge cluster randomized trials when treatment effects vary by exposure time or calendar time. Stat Med. 2025;44:e70256. doi:10.1002/sim.70256